BSE filing, NSE: RANEHOLDIN. Summary written from the filing by ALFA Finder's alert engine.
Rane Holdings Ltd: key numbers
- Share price
- ₹1,459.20
- Market cap
- ₹2,083 Cr
- Revenue (annual)
- ₹5,883 Cr
- Net profit (annual)
- ₹97.87 Cr
- P/E (TTM)
- 24.7×Sector 21.4×
- Promoter holding
- 46.64%+0.01% QoQ
- FII holding
- 0.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rane Holdings Ltd
All →Rane Holdings Acquisition Worth ₹80.85 Cr
Rane Holdings approved a RS80.85 Crore subscription to its joint venture ZF LIFETEC Rane Automotive's rights issue. RHL retains 49% post-investment, funding the JV's capex.
- Value
- ₹80.85 Cr
- Execution
- On or before October 31, 2026
Rane Holdings Credit Rating
CRISIL Ratings has assigned 'CRISIL AA-/Stable' for long-term and 'CRISIL A1+' for short-term debt facilities of Rane Holdings Limited. This action confirms the current credit assessment.
Rane Holdings Other Announcement
Rane Holdings Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Rane Holdings Legal & Regulatory
Rane Holdings' subsidiary Rane Steering Systems received a GST order dropping a tax demand of ₹10.07 Crore. The proceedings are concluded in the company's favor.
- Value
- ₹10.07 Cr
Rane Holdings Promoter Buying (Off-Market)
Promoter Meenakshi Ganesh acquired 1,348 shares of Rane Holdings Limited through share transmission. The promoter's stake increased by 0.01%.
- Promoter stake change
- +0.01%
Rane Holdings Board Meeting Date
Rane Holdings Ltd has scheduled a board meeting on November 12, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.